Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Net Cash Flow (2023 - 2026)

Cannabis Bioscience International Holdings filings provide 4 years of Net Cash Flow readings, the most recent being -$14597.0 for Q1 2026.

  • On a quarterly basis, Net Cash Flow fell 3115.2% to -$14597.0 in Q1 2026 year-over-year; TTM through Feb 2026 was -$111398.0, a 45183.74% decrease, with the full-year FY2025 number at $12197.0, up 249.51% from a year prior.
  • Net Cash Flow reached -$14597.0 in Q1 2026 per CBIH's latest filing, down from -$5493.0 in the prior quarter.
  • The five-year high for Net Cash Flow was $12404.0 in Q2 2025, with the low at -$103712.0 in Q3 2025.
  • A 4-year average of -$10379.9 and a median of -$454.0 in 2025 define the central range for Net Cash Flow.
  • Peak annual rise in Net Cash Flow hit 31905.13% in 2025, while the deepest fall reached 48563.55% in 2025.
  • Year by year, Net Cash Flow stood at -$4410.0 in 2023, then skyrocketed by 100.75% to $33.0 in 2024, then crashed by 16745.45% to -$5493.0 in 2025, then crashed by 165.74% to -$14597.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Net Cash Flow are -$14597.0 (Q1 2026), -$5493.0 (Q4 2025), and -$103712.0 (Q3 2025).